About the Event
In this installment of Diagnostic Medicine Grand Rounds, Max Wintermark, M.D., M.S., MBA, presents “Neuroimaging of Mental Health Disorders.” Wintermark serves as chair and a professor in the Department of Neuroradiology at The University of Texas MD Anderson Cancer Center.
Register to attend.
Email Meredith Lathrop for more information.
Learning Objectives
By the end of this presentation, the audience participant should be able to:
- Identify key neuroimaging modalities used in evaluating mental health disorders
- Describe imaging-based biomarkers that contribute to the detection or characterization of mental health disorders
- Explain how neuroimaging findings can guide treatment selection, monitoring or prognostic decision-making in mental health care
Target Audience
- Primary: Department of Diagnostic Medicine faculty and staff
- Secondary: Other interprofessional and multidisciplinary health care providers
Attributes/Competencies
This activity has been designed to promote some of the following desired physician attributes and competencies:
- ACGME: Patient Care/Procedural Skills; Medical Knowledge; Systems-Based Practice; Professionalism; Interpersonal and Communication Skills
- IOM: Provide Patient-Centered Care; Employ Evidence-Based Practice; Apply Quality Improvement; Work in Interdisciplinary Teams; Utilize Informatics
- IECC: Interprofessional Teamwork and Team-Based Practice; Interprofessional Communication; Roles and Responsibilities; Values and Ethics for Interprofessional Practice
Speaker Disclosure
Max Wintermark, M.D., M.S., MBA, speaker for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Planner Disclosure
Chang Ho, M.D.; Jeff Wood, M.D.; Amy Coffey, M.D.; Jacob Smith, M.D.; Jack Virostko, Ph.D.; John Pruitt, M.D.; Allie Kroes, M.D.; Elizabeth Granstrand; and Meredith Lathrop, planners for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.
James Leake, M.D., planner for this educational activity, has individual stock in Telix Pharmaceuticals and NeOnc Technologies.
The CME Advisory Committee, reviewers of this educational activity, do not have relevant financial relationship(s) with ineligible companies to disclose.
All the relevant financial relationships listed for these individuals have been mitigated.
Accreditation Statement
The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas at Austin Dell Medical School designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.